Status:
ENROLLING_BY_INVITATION
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
European Research Council
Conditions:
Paget Disease
Eligibility:
All Genders
Brief Summary
Paget's disease of the bone (PDB) is a metabolic bone disorder which in some individuals can cause pain, bone deformity, arthritis and deafness, although in many patients it does not cause symptoms. P...
Detailed Description
It is at present unclear whether intervention with bisphosphonates is of clinical benefit in early PDB. Although the ZiPP study is expected to provide information on whether ZA can favourably influenc...
Eligibility Criteria
Inclusion
- Subject that participated in ZiPP
- Participant willing and able to consent and comply with the study protocol.
Exclusion
- Unable or unwilling to provide informed consent
Key Trial Info
Start Date :
April 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
287 Patients enrolled
Trial Details
Trial ID
NCT03859895
Start Date
April 5 2019
End Date
May 1 2027
Last Update
February 14 2025
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Geelong
Geelong, Australia, 3220
2
Sir Charles Gardner Hospital
Nedlands, Australia, 6009
3
Royal Newcastle Centre
Newcastle, Australia, NSW 2305
4
University of Sydney
Sydney, Australia